Drug Search Results

Isoxsuprine

Alternative Names: isoxsuprine
Latest Update: 2024-02-06
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: ADRA Antagonist,ADRB Agonist

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Indications: None

Known Adverse Events: None

Company: University of New Mexico
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Isoxsuprine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Multiple Sclerosis

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
NCT03752307	P2	Completed	Multiple Sclerosis	2023-07-06

Recent News Events

Date	Type	Title
08/30/2023	PubMed	Formulation and Therapeutic Evaluation of Isoxsuprine-Loaded Nanoparticles against Diabetes-Associated Stroke.
07/20/2023	PubMed	Vaginal Drain to Prevent Ascending Infection in Preterm Premature Rupture of Membranes: A Novel Method.
12/01/2022	PubMed	Effects of tocolytic drugs (isoxsuprine hydrochloride) during the implantation period in pregnant sheep.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions